HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonieta Salud-Salvia Selected Research

Oxaliplatin (Eloxatin)

11/2020FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonieta Salud-Salvia Research Topics

Disease

2Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 11/2020
2Neoplasms (Cancer)
04/2024 - 12/2012
1Adenocarcinoma
02/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013
1Papillomavirus Infections
02/2013

Drug/Important Bio-Agent (IBA)

1Cell-Free Nucleic AcidsIBA
04/2024
1Bevacizumab (Avastin)FDA Link
11/2020
1Irinotecan (Camptosar)FDA LinkGeneric
11/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2020
1Leucovorin (Folinic Acid)FDA Link
11/2020
1Fluorouracil (Carac)FDA LinkGeneric
11/2020
1Biomarkers (Surrogate Marker)IBA
11/2020
1Tyrosine Kinase InhibitorsIBA
02/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2013

Therapy/Procedure

1Therapeutics
11/2020
1Immunotherapy
12/2012